They had a release. It states Pakistan / India - they've had no response to continue their studies. SEC investigation... still ongoing. And Potential issue from how the FDA perceives their work... however, they do not expect impacts and have mitigations.
I wonder why the Pakistan and India "trials" haven't moved forward. The results were good, it seems.
News 
Market Data 
Discover 
